Smartleaf Asset Management’s Agilon Health AGL Stock Holding History

Smartleaf Asset Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$860	Buy	+11	New	+$1.07K	﹤0.01%	3235

Other funds holding AGL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Smartleaf Asset Management's AGL Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Agilon Health (AGL) in Q3 2026: 11 shares worth $860. The stake represents ﹤0.01% of the portfolio and ranks #3235 among its holdings.

81 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

Smartleaf Asset Management held 11 shares of Agilon Health worth $860 as of Q3 2026.
Agilon Health was a new Smartleaf Asset Management position in Q3 2026.
Agilon Health made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3235 holding.
81 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.